Aradigm Overview

  • Founded
  • 1991
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Bankr. Admin/​Reorg
  • Financing Rounds
  • 13

Aradigm General Information

Description

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 3929 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aradigm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial

Aradigm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered b
Drug Discovery
Hayward, CA
23 As of 2017
00000
0000000000.

00000000

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000 000000000
Lake Forest, IL
00 As of 0000
00000
000000000 00000

000-000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
0000 000000000
Vienna, VA
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aradigm Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Assertio Therapeutics Formerly VC-backed Lake Forest, IL 00 00000 000000000 00000
000-000 Corporate Backed or Acquired Vienna, VA 00 000.00 000000000 000.00
0000000000 0000000 Venture Capital-Backed Brighton, United Kingdom 00 000.00 00000000000 000.00
000000 000000 Corporation London, United Kingdom 00 00000 000000000 00000
00000 000000000000 Corporation Chandler, AZ 00 000.00 0000000000.
You’re viewing 5 of 14 competitors. Get the full list »

Aradigm Executive Team (12)

Name Title Board Seat Contact Info
James Blanchard Principal Scientist
You’re viewing 1 of 12 executive team members. Get the full list »

Aradigm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aradigm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial